Methods for determining therapeutic index from gene expression profiles
AssigneeRosetta Inpharmatics LLC
InventorsMatthew Marton, Roland Stoughton
Life of this patent
Estimating the term…
Loading patent…
AssigneeRosetta Inpharmatics LLC
InventorsMatthew Marton, Roland Stoughton
Estimating the term…
This invention provides methods for determining drug specificity, therapeutic index and effective doses for individual patients. According to the methods of the invention, graded levels of drug are applied to a biological sample or a patient. A plurality of cellular constituents are measured to determine the activity of the drug on a target pathway and at least one off-target pathway. A drug specificity is determined by comparing the target and off target activities of the drug. A therapeutic concentration (or dose) is defined as a concentration (or dose) of the drug that induces certain response in the target pathway. A toxic concentration (or dose) is defined as a concentration (or dose) of the drug that induces certain response in the off target pathway. Therapeutic index is the ratio of the toxic concentration over therapeutic concentration. Methods are also provided to determine an effective dose of a drug for a patient by measuring the activity of the drug on the particular patient.
A method for monitoring a therapy for a patient, said therapy comprising administering a drug to said patient, said method comprising comparing activity of said drug on its target pathway (Dtarget) and at least one off-target pathway (Doff-target) in said patient, wherein said Dtarget and Doff-target are based on measurements of a plurality of cellular constituents.
A method for monitoring treatment with a drug for a patient comprising
A method for monitoring a therapy for a patient, said therapy comprising administering a drug to said patient, said method comprising:
A method for monitoring a therapy for a patient, said therapy comprising administering a drug to said patient, said method comprising decomposing a drug response profile into one or a combination of pathway response profiles, wherein said drug response profile comprises measurements of a plurality of cellular constituents in cells of said patient in response to administration of said drug over a plurality of levels of drug dosage, and each said pathway response profile comprises measurements of a plurality of cellular constituents at a plurality of levels of perturbation to a biological pathway, thereby monitoring said therapy.
Dependencies are inferred from the claim text.